CanSino Biologics

CanSino Biologics is a company listed under the stock ticker 688185 (CN).

View the org chart displaying its 17 main executives

Most searched biographies at CanSino Biologics

• Xuefeng Yu, Executive Chairman Of The Board, Chief Executive Offic...
• Shuifa Gui, Director
• Xiao Zhi, Non-Executive Independent Director

Create your alert
to follow the executive moves at CanSino Biologics.

CanSino Biologics has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by CanSino Biologics

Social media about CanSino Biologics

• CanSino Biologics on Wikipedia, Google News & Yahoo Finance
• CanSino Biologics on LinkedIn, Twitter & YouTube

Contact by email its executives including Xuefeng Yu

Call CanSino Biologics at +86 225...

View the org chart

Register to receive your alert

Report an error